Quote

My passion for innovation and my interest in the 'business of science' has seen Biocon commercialize many innovative platforms and products.

Biotech research is incredibly important for health-care innovation.

My main interest is in cultivating my company.

Industries with rapid change are the enemy of the investor. Tech businesses, particularly biotech, is a problem from that point of view. All industries work with change, but you should ideally be investing in businesses with a low rate of change, not a high rate of change.

We're starting to see a renaissance of investors embracing the idea that scientists can build businesses.

There's a lot of what I call 'bio-babble' and hype out there from a lot of bioenergy companies.

It was a chance encounter with a biotech entrepreneur from Ireland that got me started as an entrepreneur in India, because I partnered this Irish company in setting up India's first biotech company.

I'm primarily just an investor.

First of all, at any company, the investment in research and development in the products is the lifeblood, so that is a critical element of anyone's future going forward.

If you're a technology investor, and you decide that you're also going to be a healthcare investor or a green-tech investor, that doesn't usually work out that well. There are reasons why people make their careers studying these things and becoming experts.